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It has been suggested that patients with bleeding varices and hypersplenism will show significant improve-
ments in leucocyte and platelet counts following distal splenorenal (Warren) shunt surgery. Whilst this may
be true in the short term, this report shows that in the long term hypersplenism is not relieved, whereas the
lienorenal shunt is associated with a return ofnormal haematological values.
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INTRODUCTION
Hypersplenism may be present in 55% of patients with portal hypertension 1. It
produces a pancytopaenia and is usually associated with an enlarged spleen. It is the
result ofhyperplasia ofthe reticulo-endothelial system within the spleen and not merely
a consequence of the portal hypertension and venous congestion. The leucopaenia,
which affects mainly the polymorph population, is usually of the order of 2.5- 3.0 x
109/1. Thrombocytopaenia is not usually severe; quite commonly there is a mild
anaemia with a reduced red cell count. It is uncertain whether these changes result in
the development of symptoms. However, in patients who have bled from varices the
lowered platelet count may be a factor in the delay of spontaneous cessation of the
bleeding, and a lowered polymorph count may predispose to infection.
Hypersplenism in association with portal hypertension may clearly be dealt with by
the removal of the spleen and the construction ofa lienorenal shunt. It is questionable,
however, whether the simple reliefofpressure in the splenic venous system is sufficient
to correct the haematological changes. This study was performed to examine the course
of patients undergoing shunt surgery for actively bleeding oesophageal varices and
compared the haematological changes following: a) a lienorenal shunt [LRS] (reliefof
portal hypertension and splenectomy); b) a central portosystemic shunt [portacaval or
mesocaval shunt PSS] (relief of portal hypertension leaving the spleen in situ); and c)
a distal splenorenal (Warren) shunt [DSRS] (selective decompression of the spleen).
*Correspondence to: Mr J. P. A. Lodge, University Department of Surgery, Clinical Sciences Building, St.
James’s University Hospital, Beckett Street, Leeds LS9 7TF.
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PATIENTS AND METHODS
In this retrospective study we analysed patients undergoing shunt surgery for actively
bleeding oesophageal varices over a 15 year period (1971-1986) and followed their
leucocyte and platelet counts over a follow up period of at least one year. During this
period 116 shunt procedures were performed: 28 LRS, 35 PSS, and 53 DSRS. A
summary of diagnoses is shown in Table 1. White blood cell and platelet counts were
recorded at admission, discharge from hospital (average hospital stay 29 days) and at
one year post-operation. Hypersplenism was defined as leucopaenia (white cell count
less than 5 x 107/1) and/or thrombocytopaenia (platelet count less than 140 x 1012/1),
figures used routinely by our haematology laboratory and based on studies of all
patients entering Yorkshire hospitals or donating blood over a number of years.
Elevation ofcounts to above these figures qualified as relief of hypersplenism.
RESULTS
Twenty-three of the 53 DSRS, 17 of the 28 LRS and 13 ofthe 35 PSS patients survived
with adequate follow up for inclusion in this study. Preoperatively 14 of the 23 DSRS,
16 of the 17 LRS and 3 of the 13 PSS patients were defined as hypersplenic. The
diagnoses of these patients are shown in brackets in Table 1.
Table 1 Diagnosis
Hypersplenic
DSRS LRS PSS
8 (3) 0 5
17 (9) 8 (8) 6 (2)
2 (2) 8 (8) 2 (1)
Figures in brackets: Hypers’plenic patients with adequate follow-up.
Alcoholic Cirrhosis
Other forms of Cirrhosis
Non-Cirrhotic Portal Hypertension
Normosplenic
DSRS LRS PSS
8 2 3
18 5 12
0 5 7
To determine the effectiveness of selective splenic decompression the white cell and
platelet counts of the hypersplenic DSRS and LRS patients were compared (Figures
and 2). All patients undergoing LRS had platelet counts at or above normal at
discharge and at one year; 3 had a relative leucopaenia at discharge but all white cell
counts were normal by one year. In contrast, all but 4 patients with DSRS showed
improvement of leucocyte and platelet counts at discharge, but by the end ofone year
only 3 patients could be classified as having normal counts. Furthermore, analysis of
the haematological parameters in the 9 DSRS patients who were normosplenic pre-
operatively showed that only one patient remained normosplenic by one year, the other
8 being classified as hypersplenic by their white cell count (2 patients), platelet count (3
patients) or both (3 patients) (Figure 3).
In the PSS group the 3 patients classified as hypersplenic preoperatively remained
so, although in all 3 the thrombocytopaenia had resolved by discharge and this change
was maintained it one year in 2. None of the normosplenic PSS patients became
hypersplenic (Figure 4).DOES DSRS CORRECT HYPERSPLENISM 43
WHITE BLOOD CELL COUNT
eLRS oDSRS
p < 0.005 p < 0.05 p < 0.005
26
2
22
21
0
19
18
17
15
14
13
11 c
lO
OoO
C o
Admission Discharge Year Post-Op
Figure 1 White blood cell counts in DSRS and LRS patients who were hypersplenic preoperatively.44 J.P.A. LODGE ETAL.
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Figure 2 Platelet counts in DSRS and LRS patients who were hypersplenic preoperatively.
(Figure and 2: Median and interquartile ranges emphasised and statistical differences between the
two shunt groups noted at the top of each column. N.S. not significant; statistical analysis by Mann
WhitneyU test).DOES DSRS CORRECT HYPERSPLENISM 45
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Figure 3 White blood cell and platelet counts in DSRS patients who were normosplenic preoperatively.46 J.P.A. LODGE ETAL.
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Figure 4 White blood cell and platelet counts in PSS patients. (PCS portacaval shunt; MCS mesocaval
shunt).
(Figure 3 and 4: Median and interquartile ranges emphasised. Mann Whitney U test used to compare
discharge and one year values with preoperative figures. N.S. not significant).DOES DSRS CORRECT HYPERSPLENISM 47
DISCUSSION
Hypersplenism has not been judged to be a contraindication to distal splenorenal
(Warren) shunt surgery as in the short term significant improvements in leucopaenia
and thrombocytopaenia have been observed1- 6, and this shunt remains the surgical
treatment of choice for variceal bleeding in several major institutions6’7’8. However,
these studies looked only at- short term follow-up in the majority of patients and
they failed to take into account the natural fluctuation in the degree of hyper-
splenism that may be present at any one time9. A recent comprehensive review by
Henderson has debated the advantages of selective shunting procedures1. Our own
work has shown no significant differences in short olr long term results ofthe DSRS
and LRS in a non-randomised retrospective study
The recurrence of thrombocytopaenia has been proposed as an indicator of shunt
thrombosis, but there is no definite evidence to support this. This complication affected
only one of the hypersplenicDSRS patients included in this study. A recent case report
of a patient who redeveloped hypersplenism following a DSRS when his condition
became complicated by cardiomyopathy an.l congestive heart failure implicated a
recurrence of splenic congestion as the causeZ.
Our results suggest that although decompression ofthe spleen may be accomplished
by the DSRS, the deleterious effect ofhypersplenism on peripheral blood continues as
in the non-operated patient; and splenectomy, as in the LRS, should be considered in
the hypersplenic patient with bleeding varices.
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INVITED COMMENTARY
J. P. A. LODGE ET AL.
Several studies including the one by Lodge and associates in this issue ofHPB Surgery
have shown that hypersplenism is commonly associated with portal lypertension.
Although splenic congestion may be one causative factor, the severity of hypersplen-
ism appears to be more closely reled to the degree of portal-systemic shunting than
to the magnitude of portal pressurC. One possible mechanism for the hyperplasia of
the splenic component of the reticuloendothelial system is antigenic stimulation by
gut-derived antigens that escap Kupffer cell sequestration via intra- or extra-hepatic
portal-systemic shunt pathways. Spleen size and severity ofhypersplenim tend to be
greater in nonalcoholic cirrhotics than in patients with alcoholic cirrhosis The reasons
for the difference between alcoholics and nonalcoholics is not clear.
Several investigations have addressed the issue of how effective nonselective and
selective shunts are in relieving preoperative hypersplenism. Most studies4-7 have
shown a beneficial effect of portal decompression on hypersplenism and the improved
white blood cell and platelet counts have persisted into the late postoperative interval
in some of these series.’J One investigation has shown no consistent influence of the
portacaval shunt on hypersplenism8. The negative results of this study may be due to
the predominance of alcoholic cirrhotics who may suppress platelet, red cell and white
cell production via the toxic effects of alcohol on the bone marrow.
However, the most important point concerning the study by Lodge and associates
is that hypersplenism secondary to portal h3ypertension is almost never clinically
significant(platelet count less than 25,000/mm and/or white blood cell count less than
1,500/mm). None ofthe patients in their series had clinically significant hypersplenism
and, after operating on nearly 200 patients for variceal hemorrhage, I have personally
encountered only three individuals with life-threatening hypersplenism, who required
splenectom as a component oftheir operation. The controlled trial by Mutchnick and
co-workers, which failed to show a beneficial effect of the portacaval shunt on
hypersplenism, contained no patients with clinically significant hypersplenism and
none developed severe thrombocytopenia or leukopenia during the average follow- up
ofmore than five years.
Thus, the presence or absence of hypersplenism should almost never be a factor
determining the selection of operation for variceal hemorrhage. Rather, the effect of
the operation on frequency of recurrent hemorrhage and duration and quality of life
should be the major considerations influencing choice of procedure. Nonselective and
selective shunts are more effective than nonshunting operations for prevention of
rebleeding9. No controlled trial has demonstrated the superiority ofone operation over
another with respect to duration of survival. Of the seven controlled investigations of
the distal splenorenal shunt versus a variety of nonselective shunts, four have shown a
significantly lo,wer frequency ofpost-shunt encephalotathy after the distal sp.lenorenal
11,12 shunt and three have demonstrated no difference. Two of these trials have
compared the distal splenorenal shunt to the conventional plenorenal shunt, the two
procedures evaluated by Lodge and associates. One studyIL revealed infrequent ence-
phalopathy after both procedures and the distal splenorenal shunt resulted in fewer
neuroosychological disturbances than the conventional splenorenal shunt in the
other2.
Based on the controlled data available, I prefer the selective, distal splenorenal shunt
to nonselective shunts, including the conventional splenorenal shunt, for surgicalDOES DSRS CORRECT HYPERSPLENISM 49
management of variceal hemorrhage. Unless hypersplenism is clinically significant in
patients with portal hypertension, its presence should not be a determining factor in
choice of operation.
Layton F. Rikker,
Department of Surgery,
University ofNebraska Medical Center,
Omaha, Nebraska, USA.
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